Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Sequencing for BRAF+, RAS+, HER2- Left-Sided CRC

March 29th 2019

Multidisciplinary Approach to Resection in mCRC

March 29th 2019

Tissue-Based Testing Versus Liquid Biopsy in mCRC

March 29th 2019

Considering the Basics in Newly Diagnosed mCRC

March 29th 2019

Molecular Markers Gaining Greater Influence in CRC Paradigm

March 27th 2019

Mohamed E. Salem, MD, highlights ongoing research efforts to potentially improve survival in patients with metastatic colorectal cancer.

Testing, Treatment Options Added to NCCN CRC Guidelines

March 25th 2019

A theme of the 2019 NCCN Annual Conference was the expansion of biomarker testing to guide treatment, and a review of brand-new changes for guidelines in colorectal cancer was no different.

Germline Testing Emphasized in NCCN Guidelines on Pancreatic Cancer

March 22nd 2019

In recent years, pancreatic has passed breast cancer as the third leading cause of cancer death in the United States, and by 2030 it could be the leading cause.

Hepatocellular Carcinoma's Future Treatment Paradigm

March 22nd 2019

Ramucirumab's Role in Managing HCC

March 22nd 2019

Considering Adverse Events in Hepatocellular Carcinoma

March 22nd 2019

Sequencing Agents in HCC Based on Patient Subgroups

March 22nd 2019

Approaching Sequencing in HCC: Second-Line Therapy

March 22nd 2019

Frontline Therapy for HCC: Optimizing Treatment Selection

March 22nd 2019

Hepatocellular Carcinoma: Switching to Systemic Therapy

March 22nd 2019

Understanding Biology and Patient Subsets in HCC

March 22nd 2019

Key Trials Seek to Expand on Efficacy, Tolerability of Treatment Regimens in Refractory CRC

March 22nd 2019

Iman Imanirad, MD, discusses these trials in depth and their impact on patients with refractory metastatic colorectal cancer.

Dr. Mehta on Immunotherapy in Gastric/GEJ Cancer

March 22nd 2019

Rutika Mehta, MD, MPH, gastrointestinal medical oncologist at Moffitt Cancer Center, discusses the use of immunotherapy in patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Leveraging Limited Data in Metastatic Pancreatic Cancer

March 22nd 2019

Damian Laber, MD, provides a brief history of the trials that led to current frontline and second-line standards for patients with metastatic pancreatic cancer and shares his hope for the future of the treatment paradigm.

Dr. Mahipal on Treatment of Newly Diagnosed mCRC

March 22nd 2019

Amit Mahipal, MBBS, professor of medicine, Mayo Clinic, discusses the treatment of patients with newly diagnosed metastatic colorectal cancer.

GI Oncologist Sheds Light on Present and Future of mCRC Treatment

March 21st 2019

Amit Mahipal, MBBS, discusses navigating the complex treatment paradigm of metastatic colorectal cancer and sheds light on how recent advances are impacting the outlook of those affected by the disease.